Skip to main content
Clinical Trials/IRCT20190806044451N2
IRCT20190806044451N2
Completed
Phase 3

Evaluation of the effects of combination therapy of pentoxifylline and losartan in comparison with losartan alone on diabetic nephropathy

Zanjan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Condition 1: Type 2 Diabetes. Condition 2: Diabetic Nephropathy.
Sponsor
Zanjan University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Type 2 diabetic patients treated with insulin and oral agents
  • GFR above 30 cc / min / 1\.73 m2
  • albuminuria above 300 mg/g

Exclusion Criteria

  • Patient dissatisfaction
  • Type 1 diabetes
  • Pentoxifylline allergy
  • Chronic heart failure
  • Uncontrolled hypertension
  • Other medicines that affect albuminuria
  • Cerebral hemorrhage
  • Extensive retinal hemorrhage
  • ESRD, GFR \<30
  • Hyperkalemia (high potassium) 5\.5 before or during the study)

Outcomes

Primary Outcomes

Not specified

Similar Trials